These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1840326)

  • 21. Pharmacokinetic study in man with the non-steroidal antiinflammatory drug flunoxaprofen. Serum concentration-time profile after oral or topical preparations.
    Bareggi SR; Pedrazzini S; De Angelis M
    Arzneimittelforschung; 1988 Apr; 38(4):574-7. PubMed ID: 3401272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac.
    Barakat NS
    AAPS PharmSciTech; 2009; 10(3):724-31. PubMed ID: 19479384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of salicylic acid levels in normal subjects after rectal versus oral dosing.
    Maalouf R; Mosley M; James Kallail K; Kramer KM; Kumar G
    Acad Emerg Med; 2009 Feb; 16(2):157-61. PubMed ID: 19076101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
    Shi JM; Lai SG; Xu CJ; Duan GL; Li D
    Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective disposition of etodolac enantiomers in synovial fluid.
    Brocks DR; Jamali F; Russell AS
    J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
    Schiantarelli P; Acerbi D; Bovis G
    Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of etodolac in treatment of rheumatoid arthritis: a multicentre two-months' open study.
    Puccetti L; Soletti A; Petrini G; Remorini E; Zuccotti M; Bazzichi L; Ciompi ML
    Int J Clin Pharmacol Res; 1990; 10(6):347-53. PubMed ID: 2151575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and metabolism of [14C]-proglumetacin after oral administration in the rat.
    Makovec F; Chisté R; Peris W; Setnikar I
    Arzneimittelforschung; 1987 Jul; 37(7):806-13. PubMed ID: 3675676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
    Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of anti-inflammatory action of etodolac.
    Inoue K; Motonaga A; Nishimura T; Yokota M; Miki N; Fujisawa H; Ueda F; Shibata Y; Kimura K
    Arzneimittelforschung; 1991 Mar; 41(3):235-9. PubMed ID: 1714278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zidometacin: pharmacokinetic study on oral absorption.
    Bonardi G; Colombo F; Guenzati G; Lepore AM; Sega R
    Int J Clin Pharmacol Res; 1984; 4(6):419-23. PubMed ID: 6533086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosa.
    van Eeden A; Schotborgh RH; Tytgat GN
    Clin Ther; 1990; 12(6):496-502. PubMed ID: 2149673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopharmaceutical evaluation of carprofen following single intravenous, oral, and rectal doses in dogs.
    Schmitt M; Guentert TW
    Biopharm Drug Dispos; 1990 Oct; 11(7):585-94. PubMed ID: 2265238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal drug administration: clinical pharmacokinetic considerations.
    de Boer AG; Moolenaar F; de Leede LG; Breimer DD
    Clin Pharmacokinet; 1982; 7(4):285-311. PubMed ID: 6126289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Dalla Costa T; Lanchote VL; Schmidt S; Bulitta JB
    AAPS J; 2017 Nov; 19(6):1814-1825. PubMed ID: 28875479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.